Aesculap AG
Aesculap AG company portrait
Aesculap, a product brand in the B. Braun portfolio, is a partner for surgical and interventional treatment concepts in inpatient and ambulatory care. As one of the world's leading medical technology companies, B. Braun protects and improves the health of people around the world. For over 180 years, the family-owned company has been accelerating progress in health care with pioneering spirit and groundbreaking contributions. This innovative strength continues to be the foundation of B. Braun's success today—always with the goal of improving clinical outcomes, cost of care and patient benefits.
More than 65,000 employees live Sharing Expertise worldwide, they make B. Braun a true partner that develops smart solutions and sets new standards. By linking products, services and consulting, the company improves treatment processes and supports medical staff. In doing so, B. Braun always acts with future generations in mind, which is why responsibility for sustainable growth is embedded into all business processes. In 2022, the B. Braun Group generated sales of € 8.5 billion.
Our therapy fields
- Minimally Invasive Surgery
- Orthopedic joint replacement and regenerative therapies
- Spinal surgery
- Neurosurgery
- Interventional vascular diagnosis and therapy
- Sterile goods management
- Sutures & Surgical Specialties
